Severe COVID-19


Flemish Institute for Biotechnology Testing Leukine on COVID-19 Patients Lungs in Hopes to Prevent Dangerous ICU Cases

Investigators at the university hospital of Ghent and the Flemish Institute for Biotechnology (VIB) have commenced a clinical trial assessing the drug Leukine to identify if it could be useful in the treatment of COVID-19 patients. The Belgium-based investigators hope...

Genentech (Roche) Collaborates with BARDA to Launch Actemra Clinical Trial for Adult Patients with Severe COVID-19 Pneumonia

Genentech (Roche) plans a Phase III clinical trial to assess its marketed drug Actemra (tocilizumab) as a treatment for severe cases of COVID-19 in adults. In collaboration with the Biomedical Advanced Research and Development Authority (BARDA), the prominent company...

Pin It on Pinterest